11589918|t|Cerebrospinal fluid tau and beta-amyloid(1-42) in dementia disorders.
11589918|a|The reliability of cerebrospinal fluid (CSF)-tau and CSF-beta-amyloid assays for diagnosis of Alzheimer's disease and other dementing disorders such as frontotemporal dementia (FTD), dementia with Lewy bodies (DLB) and Creutzfeldt-Jakob disease (CJD) is reviewed. CSF assessment of the two proteins is useful in early diagnosis of AD and to differentiate it from FTD and DLB. Extremely high CSF-tau levels can discriminate CJD from AD.
11589918	20	23	tau	Gene	4137
11589918	50	68	dementia disorders	Disease	MESH:D003704
11589918	115	118	tau	Gene	4137
11589918	164	183	Alzheimer's disease	Disease	MESH:D000544
11589918	194	213	dementing disorders	Disease	MESH:D009358
11589918	222	245	frontotemporal dementia	Disease	MESH:D057180
11589918	247	250	FTD	Disease	MESH:D057180
11589918	253	278	dementia with Lewy bodies	Disease	MESH:D020961
11589918	280	283	DLB	Disease	MESH:D020961
11589918	289	314	Creutzfeldt-Jakob disease	Disease	MESH:D007562
11589918	316	319	CJD	Disease	MESH:D007562
11589918	401	403	AD	Disease	MESH:D000544
11589918	433	436	FTD	Disease	MESH:D057180
11589918	441	444	DLB	Disease	MESH:D020961
11589918	465	468	tau	Gene	4137
11589918	493	496	CJD	Disease	MESH:D007562
11589918	502	504	AD	Disease	MESH:D000544
11589918	Association	MESH:D000544	4137
11589918	Association	MESH:D007562	4137
11589918	Association	MESH:D003704	4137

